NIH may start policing conflicts

Two US Senators have introduced an amendment to the economic stimulus bill currently being debated in Congress that they say would better protect federally-funded biomedical research from potential bias. Senators Charles Grassley (R-IA) and Herb Kohl (D-WI) said in a linkurl:statement;http://grassley.senate.gov/news/Article.cfm?customel_dataPageID_1502=19157 that the amendment centers on how the National Institutes of Health polices financial conflicts among its researcher-grantees. The amendme

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Two US Senators have introduced an amendment to the economic stimulus bill currently being debated in Congress that they say would better protect federally-funded biomedical research from potential bias. Senators Charles Grassley (R-IA) and Herb Kohl (D-WI) said in a linkurl:statement;http://grassley.senate.gov/news/Article.cfm?customel_dataPageID_1502=19157 that the amendment centers on how the National Institutes of Health polices financial conflicts among its researcher-grantees. The amendment states that the NIH is to "actively enforce its conflict of interest policies and respond in a timely manner when those policies have been violated by grantees." Additionally, grantees receiving more than $250,000 per year in NIH funds (R01 awards allow for up to $250,000 in direct costs per year) would have to disclose to the agency an estimate, to the nearest $1000, of the primary investigator's significant financial interests, and a detailed plan of how the grantee's home institution will manage the conflict. Current NIH rules address conflict of interests among extramural researchers, but place the onus of managing these conflicts on grantee institutions. In recent years, Grassley has uncovered numerous examples where the agency appeared lax in its oversight of financial conflicts among its grantees. "The goal of this initiative is to establish transparency and the accountability that comes from disclosure," said Grassley in a statement. "It's become clear that the federal rules in place to manage conflicts of interest in research aren't enforced as they ought to be, and there's an opportunity to strengthen them here, as well." An amendment that raised the total amount of money that the NIH would get as part of the stimulus bill to $10 billion passed in the Senate earlier this week. Paradoxically, the Congress is not likely to finalize the NIH's 2009 budget until after the economic stimulus bill becomes law, so the agency may get a budget boost before it even resolves its base funding for 2009. "NIH grants are highly competitive," said Kohl in a statement. "The government has a right to know whether the scientists it funds have a financial stake in the outcome of their research." __Correction (02/05/09) - The original version of this story stated as $10 million the proposed bump to the NIH budget currently circulating in the Senate. That figure is $10 billion. __The Scientist__ regrets the error.__
**__Related stories:__***linkurl:NIH to act on conflicts within 1 year;http://www.the-scientist.com/blog/display/55264/
[5th December 2008]*linkurl:$500 million NIH funds boost?;http://www.the-scientist.com/blog/display/55016/
[17th September 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo